Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,116 across all filing types
Latest filing 2025-10-08 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于公司董事长和高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's chairman and senior management personnel. It details the changes in the board and senior management positions, including the names and roles of the individuals resigning and their continued roles if any. There is no financial data, no mention of a report or financial results, and the content focuses solely on management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is a direct announcement, not a report or certification.
2025-10-08 Chinese
2025年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions passed at the 2025 second extraordinary shareholders meeting of the company. It details the meeting date, voting procedures, attendance, and the voting results on specific proposals such as the election of a non-independent director and the reappointment of the audit firm. It also includes legal opinions confirming the legality of the meeting and voting process. The document does not contain financial statements or detailed financial analysis but focuses on the official voting results and meeting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not a full report but an announcement of meeting results, confirming the classification.
2025-09-29 Chinese
关于非独立董事补选完成的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the election of a non-independent director to the company's board. It includes details about the director's qualifications, compliance with legal requirements, and the board's composition. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder voting results beyond the election announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short and focused solely on this topic, confirming the classification.
2025-09-29 Chinese
关于赛隆药业集团股份有限公司2025年第二次临时股东会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, legality, and voting procedures of the 2025 second extraordinary shareholders' meeting of a company. It details the meeting's notice, attendance, voting methods, and results, and confirms the legality and validity of these procedures. It does not contain financial statements, management discussion, or financial results. It is not a report itself but a legal opinion related to a shareholders' meeting. This type of document is best classified as a Regulatory Filing (RNS) because it is a legal compliance document related to corporate governance and shareholder meetings, not a direct report like AGM materials or voting results announcements.
2025-09-29 Chinese
公司章程修正案（2025年9月）
Governance Information Classification · 100% confidence The document is titled as an amendment to the company's Articles of Association (公司章程修正案), detailing specific changes to the company's internal governance rules, such as the roles and responsibilities of the chairman, vice chairman, and board members. It discusses revisions to the company's charter and governance structure, which is typical content for a Governance Information filing. The document is relatively short (1539 characters) and does not contain financial data or report results, so it is not an Annual Report or Interim Report. It is not an announcement of a report publication but the actual governance amendment text. Therefore, the appropriate classification is Governance Information (CGR).
2025-09-19 Chinese
公司章程（2025年9月）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for 赛隆药业集团股份有限公司 (Sailong Pharmaceutical Group Co., Ltd.). It includes chapters on general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, financial accounting system, profit distribution, audit, notices and announcements, mergers, amendments to the charter, and other corporate governance matters. The content is legal and governance-related, focusing on the company's internal rules, shareholder rights, board structure, meeting procedures, and other governance practices. There is no indication of financial statements, audit reports, earnings data, or other financial disclosures. The document is not a report of financial results or an announcement of such. It is a governance document outlining the company's constitution and operational rules. Therefore, the appropriate classification is Governance Information (CGR).
2025-09-19 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.